US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist
  • 119.120
  • +0.280+0.24%
Close Apr 28 16:00 ET
  • 119.120
  • 0.0000.00%
Post 16:24 ET
17.44BMarket Cap10.65P/E (TTM)

About Biogen Company

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Company Profile

SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7605
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Viehbacher
  • Director, President and Chief Executive Officer
  • 4.07M
  • Sean Godbout
  • Vice President, Chief Accounting Officer & Global Corporate Controller
  • --
  • Susan H. Alexander
  • Executive Vice President and Chief Legal Officer
  • 6.70M
  • Robin C. Kramer
  • Chief Financial Officer
  • --
  • Dr. Ginger Gregory, PhD
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Nicole Murphy
  • Executive Vice President, Pharmaceutical Operations and Technology
  • 5.71M
  • Rachid Izzar
  • Executive Vice President, Global Product Strategy and Commercialization
  • 5.45M
  • Adam Keeney, PhD
  • Executive Vice President and Head of Corporate Development
  • --
  • Dr. Priya Singhal, M.D.,M.P.H.
  • Executive Vice President and Head of Development
  • --
  • Dr. Jane Grogan, PhD
  • Executive Vice President, Head of Research
  • --
  • Caroline D. Dorsa
  • Chairman of the Board
  • 646.13K
  • Professor Menelas Pangalos, PhD
  • Independent Director
  • --
  • Susan Langer
  • Independent Director
  • 334.53K
  • William A. Hawkins, III
  • Independent Director
  • 425.73K
  • Monish D. Patolawala
  • Independent Director
  • --
  • Jesus B. Mantas
  • Independent Director
  • 433.23K
  • Dr. Stephen A. Sherwin, M.D.
  • Independent Director
  • 435.32K
  • Dr. Maria C. Freire, PhD
  • Independent Director
  • 412.90K
  • Dr. Lloyd Minor
  • Independent Director
  • --
  • Dr. Eric K. Rowinsky,M.D.
  • Independent Director
  • 418.02K

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.